Inventor

Moussa B. H. Youdim

Inventor

Haifa, IL

Overview

1987–2018

Patent span

Human necessities

Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes29%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

C07CAcyclic or carbocyclic compounds29%

C07DHeterocyclic compounds6%

C07KPeptides3%

Y02ATechnologies for adaptation to climate change2%

C12NMicroorganisms or enzymes1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

PatentTitleYear

9,938,235Compounds with neural protective effect, and preparation and use thereof2018 9,034,303'Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof'2015 8,802,675'Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them'2014 8,685,955'Neuroprotective iron chelators and pharmaceutical compositions comprising them'2014 8,263,655'Methods for treatment of renal failure'2012 8,097,608'Methods for treatment of cardiovascular disorders and diseases'2012 8,058,442'Neuroprotective iron chelators and pharmaceutical compositions comprising them'2011 8,008,284'Methods for treatment of cardiovascular disorders and diseases'2011 RE039616'Aminoindan derivatives'2007 6,956,060'Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof'2005 6,855,711'Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators'2005 6,630,514'Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof'2003 6,538,025'Aminoindan derivatives'2003 6,528,685'Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives'2003 6,462,222'Aminoindan derivatives'2002 6,316,504'Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof'2001 6,303,650'Aminoindan derivatives'2001 6,277,886'Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan'2001 6,251,938'Phenylethylamine derivatives'2001 5,994,408'Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives'1999 5,914,349'Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives'1999 5,891,923'R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia'1999 5,880,159'Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives'1999 5,877,221'Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives'1999 5,786,390'Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan'1998 5,744,500'Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof'1998 5,668,181'Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression'1997 5,599,991'Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan'1997 5,576,353'Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds'1996 5,532,415'R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof'1996 5,519,061'R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof'1996 5,457,133'R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them'1995 5,453,446'Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson\'s disease.'1995 4,670,394'Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2014Patents assigned to TECHNION RES & DEV FOUNDATION (29)· patent assignee history

1995–2003Patents assigned to TEVA PHARMA (22)· patent assignee history

1995–2014Based in Haifa, IL· patent location history

1998–2005Based in Kiryat Tivon, IL· patent location history

2001–2003Patents assigned to YISSUM RES DEV CO (4)· patent assignee history

2001Based in Haif, IL· patent location history

2005–2014Patents assigned to YEDA RES & DEV (4)· patent assignee history

2012–2015Patents assigned to YOUDIM MOUSSA B H (5)· patent assignee history

2015Based in Nesher, IL· patent location history

2018Based in Guangzhou, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
TECHNION RES & DEV FOUNDATION	29	1995–2014
TEVA PHARMA	22	1995–2003
YOUDIM MOUSSA B Hself	5	2012–2015
YEDA RES & DEV	4	2005–2014
YISSUM RES DEV CO	4	2001–2003

Locations

Location	Patents	Span
Haifa, IL	27	1995–2014
Kiryat Tivon, IL	3	1998–2005
Guangzhou, CN	1	2018
Nesher, IL	1	2015
Haif, IL	1	2001